Over a Decade of Innovation

We are pioneering a new era of medicines
Transforming the lives of patients living with serious diseases


Across a number of disease areas

1

Approved
Therapy

5

Clinical
Programs

10

Preclinical
Programs

First-Ever Approved CRISPR-Based Therapy

CASGEVY™ (exagamglogene autotemcel), a CRISPR/Cas9 gene-edited therapy arising out of our collaboration with Vertex Pharmaceuticals Incorporated, is approved in some countries for certain eligible patients with sickle cell disease or transfusion-dependent beta thalassemia.

Learn more

COMMITTED TO PATIENTS

Developing gene-based medicines with the potential to transform the lives of people with serious diseases

Patient Advocacy

Rapidly translating a revolutionary technology into therapies

Innovation that matters

Rapidly translating a revolutionary technology into therapies

Learn more about gene editing
Science crispr x

Pushing the bounds of science

We are pioneers of the CRISPR technology and at the forefront of what’s next

Learn more about CRISPR-X

Learn more about our programs

We have established a diverse portfolio across a broad range of disease areas including hemoglobinopathies, oncology, diabetes and cardiovascular disease.

View Pipeline
Hemoglobinopathies program

Hemoglobinopathies

Aiming to treat sickle cell disease and β-thalassemia with gene-edited blood stem cells.

Learn more
Immuno oncology program

Immuno-Oncology

Creating the next generation of cell therapies for cancer enabled by gene editing.

Learn more
Getty Images 538032878

Autoimmune

Expanding cell therapies into autoimmune diseases.

Learn more
In vivo program

In Vivo

Editing cells inside the body to treat diseases.

Learn more
Regenerative medicine program

Regenerative Medicine

Broadening the applications of stem cells through gene editing.

Learn more

RECOGNIZED FOR EXCELLENCE

We take pride in delivering outstanding work, and it's an honor to have our efforts recognized. Our awards celebrate innovation, dedication, and excellence in our industry. Here are some of the accolades we've earned along the way.

Award time

TIME BEST INVENTIONS 2024

Award 50

FIERCE50 HONOREE IN INNOVATION 2024

Award nevy

NEVY AWARD IN PATIENT IMPACT 2024

Award script

SCRIP AWARD 2024

CRISPR Therapeutics Corporate Presentation

View our corporate presentation to learn more about our company.

Download Here